J H Marco Jansen Selected Research

Lymphoma (Lymphomas)

10/2021

The selection of variable regions affects effector mechanisms of IgA antibodies against CD20.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

J H Marco Jansen Research Topics

Disease

18	Neoplasms (Cancer) 01/2024 - 04/2010
2	Infections 01/2020 - 01/2018
2	Respiratory Syncytial Virus Infections 01/2020 - 01/2018
1	Communicable Diseases (Infectious Diseases) 09/2023
1	Breast Neoplasms (Breast Cancer) 01/2023
1	Lymphoma (Lymphomas) 10/2021
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2018
1	Multiple Myeloma 01/2016
1	Autoimmune Diseases (Autoimmune Disease) 01/2016
1	Melanoma (Melanoma, Malignant) 08/2014

Drug/Important Bio-Agent (IBA)

12	AntibodiesIBA 06/2023 - 04/2010
9	Immunoglobulin A (IgA)IBA 09/2023 - 12/2015
8	Immunoglobulin G (IgG)IBA 01/2020 - 08/2014
4	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2016
4	Monoclonal AntibodiesIBA 01/2020 - 12/2011
4	Fc Receptors (Fc Receptor)IBA 01/2019 - 04/2010
3	LigandsIBA 06/2023 - 01/2019
3	ErbB Receptors (EGF Receptor)IBA 08/2021 - 04/2010
2	Sialic Acid Binding Immunoglobulin-like LectinsIBA 06/2023 - 01/2023
2	Sialic AcidsIBA 06/2023 - 01/2023
2	glutaminyl-peptide cyclotransferaseIBA 08/2021 - 01/2019
2	Antiviral Agents (Antivirals)IBA 01/2020 - 01/2018
2	Palivizumab FDA Link 01/2020 - 01/2018
2	Neoplasm Antigens (Tumor Antigens)IBA 01/2020 - 01/2019
2	Cetuximab (Erbitux)FDA Link 01/2019 - 12/2015
2	Complement System Proteins (Complement)IBA 01/2019 - 12/2011
1	CollagenIBA 01/2024
1	Fc(alpha) receptorIBA 09/2023
1	SialyltransferasesIBA 01/2023
1	TransferasesIBA 01/2023
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 01/2023
1	CaspasesIBA 10/2021
1	IgA receptor (protein B)IBA 10/2021
1	IntegrinsIBA 08/2021
1	Glutamic Acid (Glutamate)FDA Link 08/2021
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2020
1	AntigensIBA 01/2020
1	Panitumumab (Vectibix)FDA Link 01/2019
1	Tyrosine (L-Tyrosine)FDA Link 01/2019
1	Immune Checkpoint InhibitorsIBA 01/2019
1	B7-H1 AntigenIBA 01/2019
1	necitumumabIBA 01/2019
1	motavizumab (Numax)IBA 01/2018
1	daratumumabIBA 01/2016
1	Trastuzumab (Herceptin)FDA Link 12/2015
1	Glycoproteins (Glycoprotein)IBA 08/2014
1	ofatumumab FDA Link 12/2011
1	Rituximab (Mabthera)FDA Link 12/2011
1	Complement Receptors (Complement Receptor)IBA 12/2011

Therapy/Procedure

8	Immunotherapy 09/2023 - 04/2010
6	Therapeutics 06/2023 - 01/2016
1	Intranasal Administration 01/2020